Cargando…
Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
Autores principales: | Villacorta, H, Martins, M Vinícius, Tinoco, E, Dohmann, HJF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301009/ http://dx.doi.org/10.1186/cc2207 |
Ejemplares similares
-
The utility of B-type natriuretic peptide in differentiating decompensated heart failure from lung disease in patients presenting to the emergency department with dyspnea
por: Villacorta, H, et al.
Publicado: (2003) -
Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003) -
Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005) -
Natriuretic peptides regulate sympathetic nervous activity independent of mineralocorticoid receptor
por: Nakagawa, Hitoshi, et al.
Publicado: (2015) -
High impact of Sepsis-related Organ Failure Assessment score on mortality prediction of patients undergoing valve replacement on the first postoperative day
por: Gomes, RV, et al.
Publicado: (2003)